Randomized study on the effectiveness, safety and acceptability 'of clobetasol propionate foam-cooled (OLUX) in comparison with cream aceponato methylprednisolone in the treatment of allergic contact dermatitis. - OLUX 01/08
- Conditions
- Patients suffering from mild to moderate DAC with interest of body surface area not exceeding 20%MedDRA version: 9.1Level: LLTClassification code 10056265Term: Allergic contact dermatitis
- Registration Number
- EUCTR2008-004331-38-IT
- Lead Sponsor
- MIPHARM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
both sexes aged between 18 and 70 years, suffering from allergic contact dermatitis mild to moderate with involvement of body surface area not exceeding 20%, providing written informed consent to participate in the study
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
allergic contact dermatitis to corticosteroids, allergic dermatitis from skin contact with interest exceeding 20%, pregnant or breastfeeding, use of corticosteroids topical or systemic in the last 4 weeks preceding the recruitment, use of immunosuppressive drugs in the last 6 months prior to recruitment , Use throughout the period of the study of cosmetic preparations can, in the opinion of the investigator, to some extent influence the assessment of the patient and / or interfere on clinical response preparations in the trial
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method